Cargando…
Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden
OBJECTIVE: Convalescent plasma has been tried as therapy for various viral infections. Early observational studies of convalescent plasma treatment for hospitalized COVID-19 patients were promising, but randomized controlled studies were lacking at the time. The objective of this study was to invest...
Autores principales: | Holm, Karin, Lundgren, Maria N., Kjeldsen-Kragh, Jens, Ljungquist, Oskar, Böttiger, Blenda, Wikén, Christian, Öberg, Jonas, Fernström, Nils, Rosendal, Ebba, Överby, Anna K., Wigren Byström, Julia, Forsell, Mattias, Landin-Olsson, Mona, Rasmussen, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642769/ https://www.ncbi.nlm.nih.gov/pubmed/34863304 http://dx.doi.org/10.1186/s13104-021-05847-7 |
Ejemplares similares
-
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases
por: Ljungquist, Oskar, et al.
Publicado: (2021) -
At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort study
por: Byström, Julia Wigren, et al.
Publicado: (2023) -
Seroprevalence of SARS-CoV-2 in Sweden, April 26 to May 9, 2021
por: Beser, Jessica, et al.
Publicado: (2022) -
Incidence, aetiology and temporal trend of bloodstream infections in southern Sweden from 2006 to 2019: a population-based study
por: Ljungquist, Oskar, et al.
Publicado: (2023) -
Evidence of household transfer of ESBL-/pAmpC-producing Enterobacteriaceae between humans and dogs – a pilot study
por: Ljungquist, Oskar, et al.
Publicado: (2016)